Wednesday, November 04, 2020 9:49:39 AM
Conference Venue: The 37th Annual J. Garber Galbraith, M.D., Scientific Session and Lecture
Title: Brain Tumor Immunology & Immunotherapy
Date/Time: Friday, Nov. 6 from 4:00 – 5:00 PM CST
Format: Guest Galbraith Lecturer
Presenting Author: Linda Liau, MD (in-person presentation)
Link: https://www.uab.edu/medicine/neurosurgery/education/continuing-medical-education/j-garber-galbraith-scientific-session-and-lecture
Socknostication: Press release after hours and before the weekend = 0% chance this happens, IMO
Conference Venue: SITC 2020
Title: Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
Date/Time: Either Wednesday, Nov. 11 from 5:15 – 5:45 PM EST or Friday, November 13 from 4:40 – 5:10 PM EST
Format: Poster Presentation – Poster available November 9th
Presenting Authors: Marnix L. Bosch, MBA, PhD; Linda Liau, MD; Keyoumars Ashkan, MD
Link: https://sitc.sitcancer.org/2020/abstracts/titles/
Socknostication: Press release after hours with TLD = 25% chance this happens, but something is afoot having these three involved in a mid-size conference, IMO
Conference Venue: SNO 2020
Title: LTBK-02 - Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma
Date/Time: Friday, Nov 20 from 11:55 – 12:05 PM EST
Format: Late Breaking Clinical Trials
Presenting Author: Linda Liau, MD
Link: https://www.eventscribe.com/2020/SNO/agenda.asp?pfp=days&day=11/20/2020&theday=Friday&h=Friday%20%20November%2020&BCFO=P|G
Socknostication: Press release embargoed and aligned with presentation = 99.9% chance this happens, IMO. Main stage at a main conference and post-DL timing to release TLD seems accurate, IMO
Recent NWBO News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 11/26/2025 05:15:34 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2025 09:23:24 PM
Eco Science Solutions Integrates IDScan.net's DIVE Into Herbo Pay to Power Identity Verification, Compliance, and Fraud Prevention • ESSI • Mar 27, 2026 12:01 PM
The Crypto Company Acquires FRAME Blockchain's Technology, An "Interstate Highway" Liquidity Layer for Crypto Commerce • CRCW • Mar 26, 2026 12:28 PM
Resilient Energy Inc. Enters LOI Negtiations for Second Acquisition; First Acquisition Nears Closing • RENI • Mar 26, 2026 10:30 AM
Alliance Creative Group (ACGX) Releases 2025 Annual Financial and Disclosure Report • ACGX • Mar 26, 2026 8:30 AM
Isiah Enterprises Activates Scalable Materials Platform Targeting $900B+ Global Market Opportunity; Initiates Strategic Partner Alignment Phase • OWPC • Mar 25, 2026 9:07 AM
ECGI Signs Definitive $25 Million Agreement to Acquire RezyFi • ECGI • Mar 24, 2026 8:30 AM
